Cytokines facilitate chemotactic motility of breast carcinoma cells

Breast Cancer

Volumn 7, Issue 3, 2000, Pages 221-230

  Arihiro, Koji ^a,b   Oda, Hiroyo ^a   Kaneko, Mayumi ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

Author keywords

Breast carcinoma cells; HGF; IL 11; IL 6; Motility

Indexed keywords

BIOMATERIAL; CHEMOTACTIC FACTOR; COLLAGEN; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; MATRIGEL; PROTEOGLYCAN; SCATTER FACTOR;

ARTICLE; BREAST TUMOR; CANCER INVASION; CELL CULTURE; CHEMOTAXIS; DRUG COMBINATION; FEMALE; FIBROBLAST; HISTIOCYTE; HUMAN; IMMUNOLOGY; LYMPHOCYTE; PATHOLOGY; SECRETION;

BIOCOMPATIBLE MATERIALS; BREAST NEOPLASMS; CHEMOTACTIC FACTORS; CHEMOTAXIS; COLLAGEN; CYTOKINES; DRUG COMBINATIONS; FEMALE; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HISTIOCYTES; HUMANS; INTERLEUKIN-11; INTERLEUKIN-6; INTERLEUKIN-8; LAMININ; LYMPHOCYTES; NEOPLASM INVASIVENESS; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0034566518     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967464     Document Type: Article

References (50)

1. Sakakura T, Kusano I: Tenascin in tissue perturbation repair. Acta PatholJpn 41:247-258, 1991.
2. Ishihara A, Yoshida T, Tamaki H, et al: Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1:1035-1041, 1995.
3. van Roozendaal CEP, van Ooijen B, Klijn JGM: Stroma influences on breast cancer cell growth. Br J Cancer 65:77-81, 1992.
4. Adam L, Crepin M, Lelong J-P, et al: Selective interactions between mammary epithelial cells and fibroblasts in co-culture. Int J Cancer 59:262-268, 1994. (Pubitemid 24343371)
5. Bani D, Riva A, Bigazzi M, et al: Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin. Br J Cancer 70:900-904, 1994. (Pubitemid 24331083)
6. Ito A, Nakajima S, Sasaguri Y, et al: Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metaUoproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71:1039-1045, 1995.
7. Matsumoto K, Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600, 1996. (Pubitemid 26131762)
8. Tuck AB, Park M, Sterns EE, et al: Coexpression of hepatocyte growth factor and receptor (met) in human breast carcinoma. Am J Pathol 148:225-232, 1996. (Pubitemid 26022451)
9. Yamashita J, Ogawa M, Yamashita S, et al: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54:1630-1633, 1994. (Pubitemid 24116158)
10. Yao Y, Jin L, Fuchs A, et al: Scatter factor protein levels in human breast cancers. Am J Pathol 1 49: 1707-1717, 1996.
11. Taniguchi T, Toi M, Inada K, et al: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1:1031-1034, 1995.
12. Toi M, Taniguchi T, Ueno T, et al: Significance of circulating hepatocyte growth factor as a prognostic indicator in primary breast cancer. Clin Cancer Res 4: 659-664, 1998. (Pubitemid 28193565)
13. Jin L, Fuchs A, Schnitt SJ, et al: Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79:749-760, 1997. (Pubitemid 27076341)
14. Van Snick J: Interleukin-6: an overview. Annu Rev Immunol 8:253-278, 1990.
15. Zhang GJ, Adachi I: Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1527-1432, 1999.
16. Fontanini G, Campani D, Roncella M, et al: Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer 80:579-584, 1999. (Pubitemid 29213216)
17. Fourcin M, Chevalier S, Lebrun JJ, et al: Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor, Eur J Immunol 24: 277-280, 1994. (Pubitemid 24014711)
18. Mukaida N, Harada A, Yasumoto K, et al: Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor. Microbiol Immunol 36:773-789, 1992.
19. Arihiro K, Inai K, Kurihara K, et al: Distribution of laminin, type IV collagen and flbronectin in the invasive component of breast carcinoma. Acta Pathol Jpn 43:758-764, 1993.
20. Saiki I, Murata J, Yoneda J, et al: Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J Cancer 56:867-873, 1994. (Pubitemid 24102755)
21. Cailleau R, Young R, Olive M, et al: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-674, 1974.
22. Crepin M, Salle V, Raux H, et al: Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell line. Anticancer Res 10:1661-1666, 1990.
23. De Leon DD, Bakker B, Wilson DM, et al: Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152:398-405, 1988.
24. Martinez-Carpio PA, Mur C, Rosel P, et al: Constitutive and regulated secretion of epidermal growth factor and transforming growth factor-beta1 in MDAMB- 231 breast cancer cell line in 11-day cultures. Cell Signal 11:753-757, 1999. (Pubitemid 29458900)
25. Brooks SC, Locke ER, Soule HD: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 2 48:6251-6253, 1973.
26. Perroteau I, Salomon D, DeBortoli M, et al: Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res Treat 7:201-210, 1986. (Pubitemid 16004887)
27. Creasey AA, Yamamoto R, Vitt CR: A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc Natl Acad Sci USA 84:3293-3297, 1987. (Pubitemid 17085389)
28. Lafon C, Mazars P, Guerrin M, et al: Early gene responses associated with transforming growth factorbeta 1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells. Biochim Biophys Acta 1266:288-295, 1995.
29. Keydar I, Chen L, Karby S, et al: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659-663, 1979.
30. Reddel RR, Murphy LC, Sutherland RL: Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res 44:2398-2405, 1984. (Pubitemid 14110657)
31. Sawyer C, Hiles I, Page M, et al: Two erbB-4 transcripts are expressed in normal breast and in most breast cancers. Oncogene 17:919-924, 1998. (Pubitemid 28430215)
32. Weidner KM, Behrens J, Vandekerckhove J, et al: Scatter factor. Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108, 1990.
33. Tajima H, Matsumoto K, Nakamura T, et al: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202:423-431, 1992.
34. Matsumoto K, Date K, Shimura H, et al: Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal flbroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 87:702-710, 1996. (Pubitemid 26261691)
35. Yi S, Chen JR, Viallet J, et al: Paracrine effects of hepatocyte growth factor/scatter factor on non-smaUcell lung carcinoma cell lines. Br J Cancer 77:2162-2170, 1998. (Pubitemid 28263936)
36. Beviglia L, Matsumoto K, Lin CS, et al: Expression of the c-Met/HGF receptor in human breast carcinoma. Correlation with tumor progression. Int J Cancer 74: 301-309, 1997. (Pubitemid 27321800)
37. Beviglia L, Kramer RH: HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cell. Int J Cancer 83:640-649, 1999. (Pubitemid 29508044)
38. Tamm I, Cardinale I, Krueger J, et al: Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170:1649-1669, 1989. (Pubitemid 19284564)
39. Tamm I, Cardinale I, Murphy J: Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci USA 88:4414-4418, 1991. (Pubitemid 21914550)
40. Tamm I, Cardinale I, Kikuchi T, et al: E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci USA 91:4338-4342, 1994. (Pubitemid 24143428)
41. Tamm I, Kikuchi T, Cardinale I, et al: Cell-adhesiondisrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 3329-3333, 1994. (Pubitemid 24130230)
42. Chiu JJ, Sgagias MK, Cowan KH, et al: Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2:215-221, 1996. (Pubitemid 26042195)
43. Youngs SJ, Ali SA, Taub DD, et al: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71:257-266, 1997. (Pubitemid 27253000)
44. Crichton MB, Nichols JE, Zhao Y, et al: Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol. Cell Endocrinol 118:215-220, 1996. (Pubitemid 26146093)
45. Weidner KM, Arakaki N, Hartmann G, et al: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88:7001-7005, 1991. (Pubitemid 21915077)
46. Seslar SP, Nakamura T, Byers SW, et al: Regulation of fibroblast hepatocyte growth factor/Scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 53:1233-1238, 1993. (Pubitemid 23097094)
47. Rosen EM, Joseph A, Jin L, et al: Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 1 27: 225-234, 1994. (Pubitemid 24307669)
48. Nakamura T, Matsumoto K, Kiritoshi A, et al: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313, 1997. (Pubitemid 27351751)
49. Moghul A, Lin L, Beedle A, et al: Modulation of c-met proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8kb c-met transcript. Oncogene 9:2045-2052, 1994. (Pubitemid 24194172)
50. Nakajima M, Chop AM: Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin Cancer Biol 2:115-127, 1991.